Reporters noted former George W. Bush Secretary of State Condoleezza Rice entering the White House on Friday, giving conservatives a chance on social media to wailReporters noted former George W. Bush Secretary of State Condoleezza Rice entering the White House on Friday, giving conservatives a chance on social media to wail

'Had to call in the professionals': Outcry as Bush advisor visits the White House

2026/03/07 05:25
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Reporters noted former George W. Bush Secretary of State Condoleezza Rice entering the White House on Friday, giving conservatives a chance on social media to wail at the alleged embrace of Bush-era neoconservatives.

NewsWire reported CNN as a source for the appearance of the former secretary, who cultivated a 20-year career as a policy expert on the Soviet Union before becoming an architect and advocate of the 2003 Iraq War. Under Bush, Rice argued for the removal of Iraqi leader Saddam Hussein for the sake of U.S. security. And she maintained that stance even after inspectors discovered no weapons of mass destruction inside Iraq’s borders.

Both progressives and hard-right MAGA enthusiasts who remember Rice’s career condemn her as a classic neocon who sent the nation down a path of expensive international nation-building that cost both lives as well as money. Analysts suspect the cost of Bush’s Iraq invasion ultimately cost the U.S. $3 trillion.

Trump, himself, stood out from his competition in the 2016 Republican primaries by slamming other Republicans’ support for wars in Iraq and Afghanistan. It is one of the reasons the anti-neoconservative wing of MAGA is so stung by Trump’s puzzling pivot into immersing the U.S. into another problematic Middle Eastern nation like Iran.

To critics, Rice’ appearance at the White House was the final proof of Trump’s embrace of old-school neoconservatism.

“Y’all wanna know how to go full neocon?” posted the Libertarian Party of Tennessee on X.

“ARE WE REALLY ENTERING ANOTHER FOREVER WAR?” said another critic on X, referencing the nation’s multi-decade involvement in Iraq and Afghanistan.

Still another X commenter suggested the Trump administration may as well bring back infamous war enthusiast and Bush policy planner Paul Wolfowitz, who argued that the invasion of Iraq was necessary after the 9/11 attacks — despite enough Saudi citizens comprising enough of the terrorist group behind the bombings that victims’ families blame the Saudi government.

“It is so over,” complained another conservative critic on X, responding to the Newswire report, while another critic claimed Trump “started a Middle East conflict so bad they had to call in the professionals.”

  • george conway
  • noam chomsky
  • civil war
  • Kayleigh mcenany
  • Melania trump
  • drudge report
  • paul krugman
  • Lindsey graham
  • Lincoln project
  • al franken bill maher
  • People of praise
  • Ivanka trump
  • eric trump
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09